ABCELLERA BIOLOGICS Cash Flow Quality Index
ABCELLERA BIOLOGICS cash flow quality index. ABCELLERA BIOLOGICS (8QQ) has a Cash Flow Quality Index of 1.75x as of December 2022. Operating cash flow of €277.36 Million exceeds net income of €158.52 Million, indicating high earnings quality where cash backs reported profits. See financial agility of ABCELLERA BIOLOGICS to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of ABCELLERA BIOLOGICS (2021–2022)
Cash flow quality index of ABCELLERA BIOLOGICS from 2021 to 2022. Historical Cash Flow Quality Index for ABCELLERA BIOLOGICS across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of ABCELLERA BIOLOGICS to assess how comfortably operating cash covers total debt obligations.
ABCELLERA BIOLOGICS Cash Flow Quality Index by Year (2021–2022)
ABCELLERA BIOLOGICS cash flow quality index by year from 2021 to 2022. Year-by-year earnings quality comparison for ABCELLERA BIOLOGICS. For the full cash flow conversion analysis, see 8QQ cash generation efficiency.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.75x | €277.36 Million | €158.52 Million | ▲ +9.8% |
| 2021 | 1.59x | €244.58 Million | €153.46 Million | — |